Board reshuffle after Kenvue deal puts governance in focus
Kimberly-Clark (KMB) just refreshed its board after completing the Kenvue acquisition, with three former Kenvue directors joining and three Kimberly-Clark directors stepping down to create room for the new appointees.
Recent trading reflects that shift in focus. Kimberly-Clark’s 1 month share price return of 14.72% and year to date share price gain of 6.76% point to building momentum, while a 1 year total shareholder return of 11.27% keeps longer term results more muted.
Scan how Kimberly-Clark fits alongside other hand-picked defensives by running the same governance and balance-sheet lens across our 29 resilient stocks with low risk scores.
After a 14.72% jump in a month and a fresh Kenvue fueled board, Kimberly-Clark now sits at a point where the harder question is simple: Is most of the upside already in the price or still ahead?
Most Popular Narrative: 7% Undervalued
Against a last close of $108.25, the most followed narrative pegs Kimberly-Clark’s fair value at $116.33. This frames the recent rally as only part of the story rather than the end of it.
Strategic refocus on higher growth, higher margin Personal Care and health oriented categories is advancing through the Arbex joint venture and the planned Kenvue acquisition. Together, these initiatives are expected to reshape Kimberly-Clark’s portfolio mix and cost base in a way that can support higher long term gross margin and EPS.
See why 97 investors see Kimberly-Clark as 7% undervalued.
Result: Fair Value of $116.33 (UNDERVALUED)
Still, that 2026 revenue guidance cut and the hit from false diaper claims in China show how quickly the Kimberly-Clark narrative could be tested.
Find out about the key risks to this Kimberly-Clark narrative.
Next Steps
Mixed feelings on Kimberly-Clark after the Kenvue deal and recent share price move. Act while the data is fresh and stress test the bullish and cautious cases yourself with the 2 key rewards and 2 important warning signs.
Looking for more investment ideas beyond Kimberly-Clark?
Do not stop at Kimberly-Clark. Use the Simply Wall Street Screener to assess your next moves across quality, value, and income before capital goes to work.
- Target potential mispricing opportunities by scanning a curated set of high quality companies with room for upside using the 34 high quality undervalued stocks.
- Strengthen portfolio resilience by focusing on businesses with cleaner finances and sturdier balance sheets through the list of solid balance sheet and fundamentals (24 results).
- Build a stream of income ideas by focusing on companies offering robust yields with the 4 dividend fortresses.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com